Podcasts

Clinical practice pearls on HRD testing workflows and reporting nuances that may shape downstream decisions…

In this AMJ Rapid Review, Zoe Diana Draelos breaks down what new 52-week findings with clascoterone cream 1% may mean for everyday…

Tune into this episode discussing the management of post-stroke spasticity to improve patient outcomes by recognising, diagnosing, and…

In this practical, case-based discussion, a breast oncology pharmacist and nurse practitioner walk through how they anticipate and…

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood…

How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer…

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the…

In this episode of Hema Now, Cynthia Dunbar discusses her pioneering career in translational stem cell biology. From the evolution of…

In this episode of Hema Now, Marilyn Manco-Johnson explores the evolution and future of paediatric haemophilia care…

How can data reveal the hidden pathways of antimicrobial resistance? The EMJ Podcast continues its special AMR series, The Silent Pandemic.

In this episode of Onc Now, Patricia Ganz sits down with EMJ to explore the evolving field of cancer survivorship….

In this series, host Saranya Ravindran speaks with Manoj Monga about kidney stone disease from first principles to future innovation. From…

In this episode of Hema Now, Karina Yazdanbakhsh speaks about her journey into immunology, the challenges of alloimmunisation, and the…

In this series, host Catherine Glass speaks with Debbie Palmer about the growing global challenge of childhood allergies and the powerful role of early-life nutrition in prevention.

In this episode, Satish Raj and Gert van Dijk explore the diagnosis, clinical burden, and management of orthostatic hypotension…

In this episode of Onc Now, Jonathan Stevenson explores the evolving field of orthopaedic oncology, highlighting the clinical challenges and innovations shaping the care of patients with bone and soft-tissue sarcomas.

In this series, host Saranya Ravindran speaks with Leslie Cho, one of the world’s leading experts in women’s cardiovascular health….

In this episode of Hema Now, Ana Boban discusses her vision as the incoming European Association for Haemophilia and Allied…

This episode explores how dermatology has become a key area for translational immunology, with recent advances enabling…

Matteo Bassetti is a leading European infectious diseases expert, guiding clinicians and policymakers on antimicrobial resistance, hospital…

In this episode of Onc Now, Michael Cecchini, Associate Professor of Medicine at Yale School of Medicine, New Haven, Connecticut, USA…

In the first instalment of our ‘Silent Pandemic’ series on AMR, host Catherine Glass speaks with Glenda Gray, paediatrician and infectious disease expert.

In this episode of Hema Now, Anna Schuh discusses the evolution of precision medicine in haematology. From her early inspiration to pursue…

In this new series, host Catherine Glass speaks with Peter N. Schlegel about the future of male infertility treatment. From decoding…

: In this episode of Onc Now, Kevin Harrington discusses the evolving landscape of head and neck cancer treatment, from the transformative…

In this series, host Saranya Ravindran speaks with Noel Bairey Merz, a global leader in women’s cardiovascular research, about how…

In this episode of Hema Now, we take a deep dive into myeloproliferative neoplasms (MPN), with a particular focus on myelofibrosis, one…

In this four-episode series, host Dr Catherine Glass speaks with Vidur Mahajan about the real-world deployment of AI in radiology. From…

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and…

In this series, host Catherine Glass speaks with Lalith Wijedoru, founder of Behind Your Mask, London, UK, about why social connection is…

In this latest episode of Hema Now, we go behind the scenes of the EAHAD 2026 Congress, exploring how the programme is developed, key emerging priorities, and what lies ahead for haemophilia care in Europe.

In this podcast, listen to Laurent Peyrin-Biroulet’s insights into the latest data from the SEQUENCE trial, including implications for…

In the final podcast of this three-part series, we hear expert insights into evolving guidelines, practical tools, and multidisciplinary…

Learn more about regenerative hepatology in this series featuring Ludovic Vallier, an expert on the development of clinically relevant cell types from human pluripotent stem cells

In this podcast episode, leading respiratory experts discuss the importance of collecting robust local data to deliver real change to the…

Robin Jones reflects on his career and explores the complexities of sarcoma care, from diagnostic challenges to evolving treatments, unmet needs, and what the future may hold for patients.

Explore innovations shaping liver transplantation, from stem cell science and bioengineered tissues to leadership, equity, and translating discovery into clinical care.

Kenneth Anderson, leading haematology expert at Dana-Farber, shares insights on multiple myeloma, drug resistance, key ASH updates, and turning…

Chronic pain, particularly in the context of rheumatic diseases, represents one of the most pervasive global health challenges, affecting…

In this series, host Saranya Ravindran speaks with Stuart Elborn about translating science into practice. They explore pivotal CF trials, novel and…

Rob Jones of the University of Glasgow shares insights on clinical trial innovation, emerging cancer treatments, and the challenges of managing toxicity in oncology care.

In this series, host Catherine Glass speaks with Michael Byrne about the rise of AI in endoscopy, tackling bias, and redefining clinical trials.

In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology…

In this special two-part episode of Onc Now, Catherine Glass returns to take you through the incredible lineup of guests from 2025.

In this series, host Saranya is joined by Nicholas Simmonds to explore the evolving landscape of cystic fibrosis in adulthood.

In this special two-part Onc Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global oncology clinicians and researchers.

David Heymann, global health leader and professor of infectious disease epidemiology, shares lessons from Ebola, SARS, smallpox, and the future of pandemic preparedness.

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

In this series, host Saranya Ravindran speaks with Lisa Saiman about the global threat of microbial infection and resistance in patients with cystic fibrosis.

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.

In this series, host Catherine Glass speaks with Katharine Phillips to explore body dysmorphic disorder beyond the skin.

Join Alessandra Gennari and Ana-Tecic-Vuger as they discuss 2 case presentations, firstly a woman with early HR+/HER2- breast Cancer and…

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

In this series, host Catherine Glass speaks with Jürgen Rockstroh about the evolving landscape of HIV care in Europe. From treatment…

In this post-ERS 2025 follow-up podcast, we take the opportunity to discuss key data presented on sustainability in respiratory…

Thoracic oncology expert Professor Nicolas Girard, discusses the evolving landscape of lung cancer treatment including current standards of care, practice-changing research, and the impact of precision medicine and immunotherapy on patient outcomes.

We delve into the science behind Refractory Chronic Cough (RCC), focusing on the role of neuronal hypersensitivity and how the cough…

In this series, host Saranya Ravindran speaks with Peter J. Mogayzel about how the USA’s approach to cystic fibrosis has evolved, from newborn screening and therapeutic guidelines to equity challenges and future research.

Arndt Vogel, Professor and Clinician Scientist at the University of Toronto, shares insights on advances in hepatocellular carcinoma, the promise of immunotherapy, and emerging biomarkers shaping liver cancer treatment.

Could gravity be the hidden force behind many of our health problems? In this series, Saranya Ravindran speaks with Brennan Spiegel, author of ‘Pull: How Gravity Shapes Your Body, Steadies the Mind, and Guides Our Health’

This podcast episode focuses on two abstracts presented at EHA 2025 on momelotinib for the treatment of myelofibrosis in patients…

How do leukaemic cells invade the central nervous system?

Experts discuss challenges within endometriosis care and cryoablation as an emerging treatment option. Navigating disease burden…

In this series, host Jonathan Sackier speaks with ImmunoProfile leaders Sudip Ghatak and Paul Olivo about how innovation, collaboration, and technology are redefining diagnostics.

How do everyday pollutants, from plastics to pesticides, shape pregnancy and child health? Find out in this series with Tracey Woodruff

How is kidney cancer care being reshaped by precision oncology and innovation? Brian Rini explores the evolution of kidney cancer treatment, highlighting breakthroughs in immunotherapy, targeted therapy, and precision oncology.   

In this new podcast episode, Lisa Machado, a patient advocate diagnosed with CML in 2008 and clinician and CML expert Jeffrey Lipton, sit…

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

Listen to experts, Klaus Schmierer, Tarunya Arun, Mavis Ayer, and Joela Mathews explore what the label expansion of cladribine tablets…

In this series, host Saranya Ravindran speaks with Holly Wyatt about the evolving landscape of obesity treatment in the era of glucagon-like peptide-1 (GLP-1) medications.

Diabetic Peripheral Neuropathy affects millions worldwide, yet it remains one of the most underdiagnosed and undertreated complications…

What does the future hold for genitourinary cancer care? Viktor Grünwald dives into precision medicine breakthroughs and reveals his vision for achieving more cures in oncology.

From identifying viral versus bacterial infections, to optimising antibiotic use in meningitis and exploring the future of vaccines, this series provides actionable insights into safeguarding children’s health worldwide.

In this special World Mental Health Day episode, Jonathan speaks with Debi Roberts about breaking down barriers to mental health conversations and creating practical pathways for suicide prevention.

How is the field of hematology evolving? In this episode, Dr. Gupta explores groundbreaking innovations from stem cell donation to the use of artificial intelligence in advancing blood science and patient care.

Step into the world of modern osteopathy with Sandy Phanor in this podcast series. From busting myths in a quickfire Q&A to exploring the emotional side of healing, Phanor shares real-world insights from the clinic.

In this episode, Claudio Cerchione recaps the 2025 International Myeloma Society (IMS) Annual Meeting, highlighting key advances in treatment, the evolving research landscape, and more.

In this first episode of the EMJ podcast series, independent health communications specialist Sue Saville is joined by renowned…

This podcast, supported by an unconditional educational grant from Chiesi Farmaceutici S.p.A., who were not involved in its creation…

In this series, host Jonathan Sackier speaks with Jed Beitler about the evolution of healthcare communications and its impact on global health.

How is scientific innovation is transforming the latest in lung cancer research and care. Chair of the Medical Oncology Department at Hospital Universitario, Luis Paz-Ares, talks about from prevention to emerging treatments in lung cancer.

Rohan Jotwani, anesthesiologist and XR/AI innovator, shares how immersive technology is transforming pain management, medical training, and more

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

This expert-led podcast explores healthcare sustainability in the face of climate change, highlighting how guideline-directed…

Gonzalo Pérez Marc, paediatrician and clinical researcher, shares insights from the BERNI study on maternal RSV vaccination and strategies to protect infants worldwide.

Refractory Chronic Cough (RCC) is more than just a lingering symptom; it’s a misunderstood condition that disrupts lives…

Sara Tolaney shares insights on breast cancer care, including her research on CDK4/6 inhibitors and exploring ways to de-escalate treatment.

Explore the dual challenge of alcohol use disorder and liver disease in this series with Stephanie Rutledge.

What are myeloproliferative neoplasms, and what can research reveal about future therapies? Andrew Dunbar explores the biology, resistance, and emerging treatment strategies.

In the first instalment of our Paediatric Infectious Diseases series, host Saranya Ravindran is joined by Debby Bogaert, world-renowned paediatric infectious disease expert, to explore the infant respiratory microbiome and its role in health and disease.

In the third episode of our Rare Lung Diseases podcast series,, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases.

How is the breast cancer landscape evolving, from HER2-low breakthroughs to the future of targeted therapy and precision care?

Catherine Glass sits down with leading diabetes researcher Vinod Patel to discuss the future of Type 2 diabetes care, exploring new technologies, predictive tools, retinal imaging, and much more.

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

In this deeply personal episode, Jonathan Sackier speaks with Zoe Strickland, author of To Grief With Love, about how she navigated the loss of her son and found space for healing through creative expression and connection.

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Explore the evolving role of methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led podcast featuring leading…

What is the link between pain and anxiety? David Cosio, Clinical Psychologist, Interdisciplinary Pain Program, Jesse Brown VA Medical, Chicago, Illinois, USA, shares the latest advances in pain management and more.

Stephen Freedland explores how lifestyle, equity, and emerging therapeutics are reshaping prostate cancer care, from risk to survivorship.

In the second episode of our Rare Lung Diseases podcast series, discover the complexities of pulmonary arterial hypertension with Neal Chaisson, Assistant Professor of Medicine at the Cleveland Clinic.

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

In the first episode of our Rare Lung Diseases podcast series, host Saranya Ravindran speaks with James Stoller, Cleveland Clinic, about Alpha-1 antitrypsin deficiency, a rare genetic condition that is frequently underdiagnosed.

In this episode Jonathan is joined by Jean Abraham, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.